Written by: Mark Wade, Global Practice Leader, TransPerfect Life Sciences
The rush to a vaccine has accelerated an already dynamic research process. This has led to many innovations and an evolution of procedures. The language translation industry has seen enormous stressors and has had to create and modify processes and technologies similarly.
The pandemic has changed society profoundly. The disruption in human and business interactions have not only affected the travel, conference, and hospitality industries but has also changed the clinical research landscape forever.
In this new white paper, Mark Wade shares how new processes and technologies are enabling higher quality translations for clinical research amid the race to a vaccine.